Literature DB >> 28882725

What is antimicrobial stewardship?

O J Dyar1, B Huttner2, J Schouten3, C Pulcini4.   

Abstract

BACKGROUND: The use of the term 'antimicrobial stewardship' has grown exponentially in recent years, typically referring to programmes and interventions that aim to optimize antimicrobial use. Although antimicrobial stewardship originated within human healthcare, it is increasingly applied in broader contexts including animal health and One Health. As the use of the term 'antimicrobial stewardship' becomes more common, it is important to consider what antimicrobial stewardship is, as well as what it is not. AIMS: To review the emergence and evolution of the term 'antimicrobial stewardship'. SOURCES: We searched and reviewed existing literature and official documents, which mostly focused on antibiotics. We contacted the authors of the first publications that mentioned antimicrobial stewardship. CONTENT: We describe the historical background behind how antimicrobial stewardship came into use in clinical settings. We discuss challenges emerging from the varied descriptions of antimicrobial stewardship in the literature, including an over-emphasis on individual prescriptions, an under-emphasis on the societal implications of antimicrobial use, and language translation problems. IMPLICATIONS: To help address these challenges, we suggest viewing antimicrobial stewardship as a strategy, a coherent set of actions which promote using antimicrobials responsibly. We stress the continuous need for 'responsible use' to be defined and translated into context-specific and time-specific actions. Furthermore, we present examples of actions that can be undertaken within antimicrobial stewardship across human and animal health.
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic stewardship; One Health; Rational antibiotic use; Responsible antibiotic use; Veterinary Antimicrobial stewardship

Mesh:

Substances:

Year:  2017        PMID: 28882725     DOI: 10.1016/j.cmi.2017.08.026

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  131 in total

1.  The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis.

Authors:  Awad Al-Omari; Abbas Al Mutair; Saad Alhumaid; Samer Salih; Ahmed Alanazi; Hesham Albarsan; Maha Abourayan; Maha Al Subaie
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-29       Impact factor: 4.887

2.  Metaphylactic Antibiotic Treatment to Prevent the Transmission of Corynebacterium bovis to Immunocompromised Mouse Offspring.

Authors:  Emily C Pearson; Umarani Pugazhenthi; Derek L Fong; Derek E Smith; Andrew G Nicklawsky; Lauren M Habenicht; Michael K Fink; Jori K Leszczynski; Michael J Schurr; Christopher A Manuel
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-09-09       Impact factor: 1.232

Review 3.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

4.  Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation.

Authors:  Hui-Han Chen; Andrew Stringer; Tadesse Eguale; Gauri G Rao; Sachiko Ozawa
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

5.  Prescribing Pattern of Antibiotics Using WHO Prescribing Indicators Among Inpatients in Ethiopia: A Need for Antibiotic Stewardship Program.

Authors:  Gebre Teklemariam Demoz; Gebremicheal Gebreslassie Kasahun; Kalay Hagazy; Gebremariam Woldu; Shishay Wahdey; Degena Bahrey Tadesse; Yirga Legesse Niriayo
Journal:  Infect Drug Resist       Date:  2020-08-11       Impact factor: 4.003

6.  Impact of Male Patient Information on Quality of Urine Examination (PIQUE Study).

Authors:  Philipp J Spachmann; Cathrin Rupp; Hans-Martin Fritsche; Stefan Denzinger; Maximilian Burger; Johannes Breyer; Wolfgang Otto; Marco J Schnabel
Journal:  Urol Int       Date:  2021-08-26       Impact factor: 2.089

7.  Towards the Prediction of Antimicrobial Efficacy for Hydrogen Bonded, Self-Associating Amphiphiles.

Authors:  Nyasha Allen; Lisa J White; Jessica E Boles; George T Williams; Dominique F Chu; Rebecca J Ellaby; Helena J Shepherd; Kendrick K L Ng; Laura R Blackholly; Ben Wilson; Daniel P Mulvihill; Jennifer R Hiscock
Journal:  ChemMedChem       Date:  2020-10-16       Impact factor: 3.466

Review 8.  Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.

Authors:  David Y Graham; Maria Pina Dore; Hong Lu
Journal:  Expert Rev Anti Infect Ther       Date:  2018-08-23       Impact factor: 5.091

Review 9.  Applications of Machine Learning to the Problem of Antimicrobial Resistance: an Emerging Model for Translational Research.

Authors:  Melis N Anahtar; Jason H Yang; Sanjat Kanjilal
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

10.  Development and Pilot of an Interactive Online Course on Antimicrobial Stewardship in Companion Animals.

Authors:  Nonke E M Hopman; Jaap A Wagenaar; Ingeborg M van Geijlswijk; Els M Broens
Journal:  Antibiotics (Basel)       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.